Ticagrelor monotherapy vs clopidogrel monotherapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention

被引：0
|
作者：
Feng, W. [1 ]
Chen, P. W. [2 ]
Ho, M. Y. [3 ]
Su, C. H. [4 ]
Huang, S. W. [4 ]
Cheng, C. W. [5 ]
Yeh, H., I [5 ]
Chen, C. P. [6 ]
Huang, W. C. [7 ]
Fang, C. C. [8 ]
Lin, H. W. [9 ]
Lin, S. H. [9 ]
Hsieh, I. C. [3 ]
Li, Y. H. [2 ]
机构：
[1] Kaohsiung Med Univ Hosp, Cardiol, Kaohsiung, Taiwan
[2] Natl Cheng Kung Univ Hosp, Cardiol, Tainan, Taiwan
[3] Linkou Chang Gung Mem Hosp, Cardiol, Taoyuan, Taiwan
[4] Chung Shan Med Univ Hosp, Cardiol, Taichung, Taiwan
[5] Mackay Mem Hosp, Cardiol, Taipei, Taiwan
[6] Changhua Christian Hosp, Cardiol, Changhua, Taiwan
[7] Kaohsiung Vet Gen Hosp, Cardiol, Kaohsiung, Taiwan
[8] Tainan Municipal Hosp, Cardiol, Tainan, Taiwan
[9] Natl Cheng Kung Univ, Tainan, Taiwan
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1722 / 1722
页数：1
相关论文
共 50 条
  • [41] Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Muhammad Shahzeb Khan
    Muhammad Mustafa Memon
    Muhammad Shariq Usman
    Saed Alnaimat
    Safi U. Khan
    Abdur Rahman Khan
    Naser Yamani
    Setri Fugar
    Farouk Mookadam
    Richard A. Krasuski
    Rami Doukky
    American Journal of Cardiovascular Drugs, 2019, 19 : 465 - 476
  • [42] Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Khan, Muhammad Shahzeb
    Memon, Muhammad Mustafa
    Usman, Muhammad Shariq
    Alnaimat, Saed
    Khan, Safi U.
    Khan, Abdur Rahman
    Yamani, Naser
    Fugar, Setri
    Mookadam, Farouk
    Krasuski, Richard A.
    Doukky, Rami
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (05) : 465 - 476
  • [43] Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention
    Abraham, Neena S.
    Yang, Eric H.
    Noseworthy, Peter A.
    Inselman, Jonathan
    Yao, Xiaoxi
    Herrin, Jeph
    Sangaralingham, Lindsey R.
    Ngufor, Che
    Shah, Nilay D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) : 646 - 654
  • [44] Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Analysis from the Acute Coronary Syndrome Israeli Survey
    Eliaz, Ran
    Mengesha, Bethlehem
    Ovdat, Tal
    Iakobishvili, Zaza
    Hasdai, David
    Kheifets, Mark
    Klempfner, Robert
    Beigel, Roy
    Kalmanovich, Eran
    Alcalai, Ronny
    Levi, Amos
    CARDIOLOGY, 2022, 147 (02) : 113 - 120
  • [45] Ticagrelor or clopidogrel in atrial fibrillation patients undergoing percutaneous coronary intervention for myocardial infarction
    Godtfredsen, S. J.
    Kragholm, K. H.
    Bekfani, T.
    Sorensen, R.
    Torp-Pedersen, C.
    Bhatt, D. L.
    Pareek, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [46] On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Laine, Marc
    Panagides, Vassili
    Frere, Corinne
    Cuisset, Thomas
    Gouarne, Caroline
    Jouve, Bernard
    Lemesle, Gilles
    Paganelli, Franck
    Alessi, Marie-Christine
    Mancini, Julien
    Bonello, Laurent
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (07) : 923 - 930
  • [47] Ticagrelor pretreatment in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention
    Graca Santos, L.
    Ribeiro Carvalho, R.
    Fernandes, S.
    Montenegro Sa, F.
    Ruivo, C.
    Soares, F.
    Correia, J.
    Pernencar, S.
    Morais, J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1724 - 1724
  • [48] Potential benefit of ticagrelor monotherapy for patients with hypertension undergoing percutaneous coronary intervention: insights from the Global Leaders trial
    Modolo, R.
    Chichareon, P.
    De Faria, A. P.
    Steg, P. G.
    Hamm, C.
    Vranckx, P.
    Valgimigli, M.
    Windecker, S.
    Onuma, Y.
    Serruys, P. W.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4008 - 4008
  • [49] Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention
    Faggioni, Michela
    Baber, Usman
    Chandrasekhar, Jaya
    Sartori, Samantha
    Claessen, Bimmer E.
    Rao, Sunil V.
    Vogel, Birgit
    Effron, Mark B.
    Poddar, Kanhaiya
    Farhan, Serdar
    Kini, Annapoorna
    Weintraub, William
    Toma, Catalin
    Sorrentino, Sabato
    Weiss, Sandra
    Snyder, Clayton
    Muhlestein, Joseph B.
    Kapadia, Samir
    Keller, Stuart
    Strauss, Craig
    Aquino, Melissa
    Baker, Brian
    Defranco, Anthony
    Pocock, Stuart
    Henry, Timothy
    Mehran, Roxana
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 275 : 31 - 35
  • [50] Antiplatelet monotherapy debate: Why not leave good old aspirin for clopidogrel or ticagrelor as monotherapy in chronic coronary syndrome after coronary angioplasty
    De Caterina, Raffaele
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (04) : 16S - 18S
12345